Nanocarriers Solve the Biggest Problems with Bioactive Peptide Delivery — Stability, Taste, and Absorption | Research

The takeaway

Encapsulating bioactive peptides in lipid, carbohydrate, or protein-based nanocarriers dramatically improves their stability, bioavailability, and taste — addressing the main barriers to using these health-promoting peptides in foods and supplements.

3 nanocarrier platforms compared
Lipid-, carbohydrate-, and protein-based nanocarriers each offer distinct advantages for protecting bioactive peptides through digestion and enhancing their absorption in the gut

What the researchers found

The review covers three main categories of nanocarriers for bioactive peptide delivery:

1. **Lipid-based nanocarriers** (liposomes, solid lipid nanoparticles, nanoemulsions) — protect peptides from gastric degradation and enhance absorption through intestinal membranes.

2. **Carbohydrate-based nanocarriers** (chitosan, alginate, starch nanoparticles) — provide pH-responsive release and mucoadhesive properties for targeted gut delivery.

3. **Protein-based nanocarriers** (casein, whey, zein) — offer food-grade compatibility and controlled release.

Across all types, nanoencapsulation improved peptide stability, solubility, resistance to gastric digestion, and bioavailability while reducing or masking undesirable flavors — the key barriers to incorporating bioactive peptides into functional foods and dietary supplements.

Why it matters

The global market for bioactive peptides in supplements and functional foods is growing rapidly, but poor bioavailability remains the biggest technical challenge. Nanocarrier technology could unlock the full potential of food-derived peptides with proven health benefits, making them viable ingredients in everyday products rather than just promising lab findings.

How the study worked

This is a comprehensive review article synthesizing recent in vitro and in vivo studies on nanocarrier-based delivery systems for bioactive peptides. It covers formulation approaches, characterization methods, biological activity assessments, and food application studies across lipid, carbohydrate, and protein-based nanocarrier platforms.

What this study cannot tell us

As a review, no new experimental data are presented. Many nanocarrier systems described have only been tested in vitro or in simple animal models — translation to commercial food products involves additional challenges like shelf stability, regulatory approval, consumer acceptance of 'nano' ingredients, and manufacturing scale-up costs. Long-term safety data for many nanocarrier materials in food applications are limited.

How to read the evidence

This is a comprehensive review article covering both in vitro and in vivo studies. While it synthesizes strong evidence for nanocarrier benefits, most individual studies cited are preclinical, and few nanoencapsulated peptide products have undergone clinical trials.

When this study was published

Published in 2024, this review captures the current state of nanocarrier-peptide research, including recent advances in food-grade nanotechnology.

The bigger picture

This review sits at the intersection of nanotechnology, peptide science, and food technology. As consumers increasingly seek functional foods with proven health benefits, nanoencapsulation could bridge the gap between peptide research and commercial products — turning bioactive peptides from laboratory curiosities into ingredients in yogurts, beverages, and supplements that actually deliver their promised benefits.

Questions still open

Which nanocarrier type offers the best balance of bioavailability enhancement, manufacturing cost, and consumer acceptance for commercial peptide supplements?
How do regulatory frameworks in different countries handle nano-encapsulated bioactive peptides in food products?
Can nanocarriers be designed to deliver peptides to specific sites in the gut for maximum therapeutic effect?

Common questions

Why can't you just eat bioactive peptides directly — why do they need nanocarriers?

Bioactive peptides face several problems when eaten: stomach acid breaks them down before they can be absorbed, they often taste bitter or unpleasant, and even if they survive digestion, they're poorly absorbed through the gut wall. Nanocarriers act as tiny protective shells that shield the peptide through the stomach, release it in the intestine, and help it cross into the bloodstream.

Are nanocarrier-encapsulated peptides safe to eat?

The nanocarriers described in this review are made from food-grade materials like fats, starches, chitosan, and milk proteins — ingredients already common in foods. However, their safety at the nanoscale is still being evaluated by regulators, and long-term studies are ongoing. Most are considered generally safe based on the materials used.

Read the original research

Loading bioactive peptides within different nanocarriers to enhance their functionality and bioavailability; in vitro and in vivo studies.

Advances in colloid and interface science, 334, 103318

View on PubMed ↗Publisher’s paper ↗

Citation

Mazloomi, Narges; Safari, Barbod; Can Karaca, Asli; Karimzadeh, Laleh; Moghadasi, Shokufeh; Ghanbari, Masoud; Assadpour, Elham; Sarabandi, Khashayar; Jafari, Seid Mahdi. (2024). Loading bioactive peptides within different nanocarriers to enhance their functionality and bioavailability; in vitro and in vivo studies.. Advances in colloid and interface science, 334, 103318. https://doi.org/10.1016/j.cis.2024.103318